🔎 Trials Near Me

Akèy › Sipwa › Distrik Columbia › Washington

Etid klinik pou Sipwa nan Washington, DC

19 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

Ap rekriteFaz 2Volontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 60 · Fanm · Mizajou Oct 2, 2026 · NCT03407079

Physical and Behavioral Traits of Overweight and Obese Adults

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00428987

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Med Home Development Grp, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Ap rekriteFaz 3
  • Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3
  • Capital Digestive Care - Chevy Chase, Chevy Chase · 8 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Ap rekriteFaz 3
  • Flourish Research - Bowie, Bowie · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07369011

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Lanham · 11 mi lwen
  • Research Site, Beltsville · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

Ap rekrite
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 18, 2026 · NCT06044935

Plant-Based Online Weight Loss Through Education and Resources Program and Study

Ap rekrite
  • Physicians Committee for Responsible Medicine, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07095543

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Children's National Hospital (CNH), Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 12 a 25 · Tout sèks · Mizajou Sep 17, 2026 · NCT06730113

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Washington D.C.
  • AURORA-2 Clinical Site, Bowie · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Washington D.C.
  • AURORA-1 Clinical Site, Bowie · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Emerson Clinical Research Institute, Washington D.C.
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Silver Spring · 7 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Prebiotic Inulin for Late-Reproductive Individuals

Ap rekrite
  • Milken Institute School of Public Health, Washington D.C.
Laj 40 a 55 · Fanm · Mizajou Aug 11, 2026 · NCT07724522

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Silver Spring · 7 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change

Ap rekrite
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 50 · Tout sèks · Mizajou Jul 31, 2026 · NCT06325722

Etid Sipwa nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.